204 related articles for article (PubMed ID: 22471341)
21. Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients.
Tural C; Galeras JA; Planas R; Coll S; Sirera G; Giménez D; Salas A; Rey-Joly C; Cirera I; Márquez C; Tor J; Videla S; García-Retortillo M; Clotet B; Solà R
Antivir Ther; 2008; 13(8):1047-55. PubMed ID: 19195330
[TBL] [Abstract][Full Text] [Related]
22. Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study.
Agüero F; Rimola A; Stock P; Grossi P; Rockstroh JK; Agarwal K; Garzoni C; Barcan LA; Maltez F; Manzardo C; Mari M; Ragni MV; Anadol E; Di Benedetto F; Nishida S; Gastaca M; Miró JM;
Am J Transplant; 2016 Feb; 16(2):679-87. PubMed ID: 26415077
[TBL] [Abstract][Full Text] [Related]
23. Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea.
Lim DH; Jeong JY; Nam S; Choi J; Kwon HC; Yoon YB; Kim Y; Chin B
J Korean Med Sci; 2021 Nov; 36(46):e308. PubMed ID: 34845874
[TBL] [Abstract][Full Text] [Related]
24. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.
Bräu N; Salvatore M; Ríos-Bedoya CF; Fernández-Carbia A; Paronetto F; Rodríguez-Orengo JF; Rodríguez-Torres M
J Hepatol; 2006 Jan; 44(1):47-55. PubMed ID: 16182404
[TBL] [Abstract][Full Text] [Related]
25. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.
Behzadpour D; Ahmadi Vasmehjani A; Mousavi Nasab SD; Ahmadi NA; Baharlou R
Pathog Glob Health; 2016; 110(7-8):310-315. PubMed ID: 27830997
[TBL] [Abstract][Full Text] [Related]
26. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals.
Corma-Gómez A; Morano L; Téllez F; Rivero-Juárez A; Real LM; Alados JC; Ríos-Villegas MJ; Vera-Méndez FJ; Muñoz RP; Geijo P; Macías J; Pineda JA;
AIDS; 2019 Jun; 33(7):1167-1174. PubMed ID: 30845068
[TBL] [Abstract][Full Text] [Related]
27. Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection.
Keiserman DR; Both CT; Mattos AA; Remiao J; Alexandre CO; Sherman KE
Am J Gastroenterol; 2003 Apr; 98(4):878-83. PubMed ID: 12738471
[TBL] [Abstract][Full Text] [Related]
28. Liver transplantation in HIV-HCV coinfected candidates: what is the most appropriate time for evaluation?
Maida I; Núñez M; González-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2005 Jul; 21(7):599-601. PubMed ID: 16060829
[TBL] [Abstract][Full Text] [Related]
29. Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients.
Locke JE; Shelton BA; Reed RD; MacLennan PA; Mehta S; Sawinski D; Segev DL
Am J Transplant; 2016 Aug; 16(8):2377-83. PubMed ID: 27140837
[TBL] [Abstract][Full Text] [Related]
30. Hemophilia Liver Transplantation Observational Study.
Ragni MV; Humar A; Stock PG; Blumberg EA; Eghtesad B; Fung JJ; Stosor V; Nissen N; Wong MT; Sherman KE; Stablein DM; Barin B
Liver Transpl; 2017 Jun; 23(6):762-768. PubMed ID: 27935212
[TBL] [Abstract][Full Text] [Related]
31. Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study.
Seyoum E; Demissie M; Worku A; Mihret A; Abdissa A; Berhane Y
BMC Public Health; 2022 Apr; 22(1):644. PubMed ID: 35379215
[TBL] [Abstract][Full Text] [Related]
32. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L;
J Hepatol; 2021 Jan; 74(1):37-47. PubMed ID: 32798585
[TBL] [Abstract][Full Text] [Related]
33. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.
Smit C; van den Berg C; Geskus R; Berkhout B; Coutinho R; Prins M
J Acquir Immune Defic Syndr; 2008 Feb; 47(2):221-5. PubMed ID: 18223361
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.
Sherman KE; Rouster SD; Stanford S; Blackard JT; Shire N; Koziel M; Peters M; Chung RT;
J Infect Dis; 2010 Mar; 201(5):712-9. PubMed ID: 20105080
[TBL] [Abstract][Full Text] [Related]
35. Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis.
Corma-Gómez A; Macías J; Lacalle-Remigio JR; Téllez F; Morano L; Rivero A; Serrano M; Ríos MJ; Vera-Méndez FJ; Alados JC; Real LM; Palacios R; Santos IL; Imatz A; Pineda JA;
Clin Infect Dis; 2021 Oct; 73(7):e2109-e2116. PubMed ID: 32766891
[TBL] [Abstract][Full Text] [Related]
36. Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection.
Martel-Laferrière V; Brinkley S; Bichoupan K; Posner S; Stivala A; Perumalswami P; Schiano T; Sulkowski M; Dieterich D; Branch A
HIV Med; 2014 Feb; 15(2):108-15. PubMed ID: 24025147
[TBL] [Abstract][Full Text] [Related]
37. Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug users.
Sanvisens A; Fuster D; Serra I; Tor J; Tural C; Rey-Joly C; Muga R
Curr HIV Res; 2011 Jun; 9(4):256-62. PubMed ID: 21675942
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus-HIV-coinfected patients and liver transplantation.
Kardashian AA; Price JC
Curr Opin Organ Transplant; 2015 Jun; 20(3):276-85. PubMed ID: 25944240
[TBL] [Abstract][Full Text] [Related]
39. Cellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patients.
Dichamp I; Abbas W; Kumar A; Di Martino V; Herbein G
PLoS One; 2014; 9(5):e96907. PubMed ID: 24809719
[TBL] [Abstract][Full Text] [Related]
40. Effect of HCV, HIV and coinfection in kidney transplant recipients: mate kidney analyses.
Xia Y; Friedmann P; Yaffe H; Phair J; Gupta A; Kayler LK
Am J Transplant; 2014 Sep; 14(9):2037-47. PubMed ID: 25098499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
